Maryland-based biotech company Novavax said Monday that its COVID-19 vaccine was shown to be highly effective in clinical trials, which puts it on track to become the fourth vaccine available in the United States. Given the abundance of vaccines in the U.S., Novavax's vaccine may... Read More.
(LONDON) -- American biotechnology company Novavax announced Monday that its experimental COVID-19 vaccine was more than 90% effective against symptomatic disease in late-stage clinical trials. Results from the Phase 3 trial, which enrolled nearly 30,000 participants across 119 sites in the United States and Mexico,... Read More.
By DR. SABINA BERA, ABC News(NEW YORK) -- Novavax, a vaccine development company, was recently awarded over $1.6 billion by the United States government to support commercial-scale manufacturing of their potential coronavirus vaccine.According to Stanley Erck, CEO of... Read More.